Tempest Therapeutics, Inc. (OVAS) [Rocket]

In millions, except per share items	Jun-30-23	Mar-31-23	Dec-31-22	Sep-30-22	Jun-30-22	Mar-31-22	Dec-31-21	Sep-30-21
	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q
Revenues								100.0%
Cost of goods sold								0.0%
Gross profit								100.0%
Research and development								112.5%
General and administrative								74.4%
Depreciation								2.2%
EBIT								-86.9%
Pre-tax income								-194.3%
Income taxes								0.0%
Net income								-194.3%